US equities |
NVDA $239.71 ▲+2.46% SPCX $169.28 ▲+6.49% MU $1,063.06 ▼-1.10% TSLA $379.79 ▲+2.48% SNDK $1,703.20 ▼-0.98% MSFT $528.01 ▲+2.03% INTC $116.10 ▼-2.71% META $742.99 ▲+2.05%
FinancialContent

OrthoPediatrics Corp. - Common Stock (NQ:KIDS)

22.57 +0.41 (+1.85%)
Delayed Quote Updated: 3:40 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OrthoPediatrics Corp. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
4 Analysts Have This to Say About OrthoPediatrics ↗
 
Via Benzinga
News headline image
OrthoPediatrics Corp. Reports Second Quarter 2023 Financial Results
Record Setting Quarterly Revenue of $39.6 million 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
Analyst Ratings for OrthoPediatrics ↗
 
Via Benzinga
News headline image
OrthoPediatrics's Earnings Outlook ↗
 
Via Benzinga
News headline image
Analyst Expectations for OrthoPediatrics's Future ↗
 
Via Benzinga
News headline image
Where OrthoPediatrics Stands With Analysts ↗
OrthoPediatrics (NASDAQ:KIDS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2023 ↗
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
News headline image
OrthoPediatrics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
First Quarter 2023 Revenue Increased 35% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting
Establishes Longer-term Commitment as an Emerald Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces Launch of RESPONSE™ 5.5/6.0 Cannulated Screw System
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 1, 2023 ↗
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
News headline image
OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Participate at the 22nd Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Leading Sponsorship at Annual EPOS Meeting
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Named One of the 2023 Best Places to Work in Indiana
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
Respiratory Infections Led OrthoPediatrics Miss Quarterly Sales Expectations, Analyst Calls It Transitory Issue ↗
 
Via Benzinga
News headline image
OrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter & Full Year 2022, Provides Financial Outlook for 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Host Educational and Networking Events at 18th Annual International Pediatric Orthopaedic Symposium (IPOS)
Continues IPOS Corporate Partnership as Double Diamond Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics to Participate in Upcoming November Conferences
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >